Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS3 | P29474 | 2/20 | 0.47 |
| ▸ | NOS1 | P29475 | 2/20 | 0.47 |
| ▸ | NOS2 | P35228 | 2/20 | 0.47 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.44 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.44 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.44 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.44 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.44 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.44 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.44 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.44 |
| ▸ | RAC1 | P63000 | 1/20 | 0.43 |
| ▸ | PAK1 | Q13153 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | TNF | P01375 | 1/20 | 0.36 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.36 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2227367 | 1.00 | NOS3 (0.47) | NOS3NOS1NOS2GRIN2DGRIN3B | |
| Hydrochloric Acid SCHEMBL14632786 | 0.97 | NOS3 (0.44) | NOS3NOS1NOS2GRIN2DGRIN3B | |
| Hydrochloric Acid SCHEMBL14632785 | 0.97 | NOS3 (0.47) | NOS3NOS1NOS2GRIN2DGRIN3B | |
| SCHEMBL24404238 | 0.93 | NOS3 (0.42) | NOS3NOS1NOS2GRIN2DGRIN3B | |
| SCHEMBL21113676 | 0.93 | NOS3 (0.42) | NOS3NOS1NOS2GRIN2DGRIN3B | |
| SCHEMBL4890079 | 0.87 | RAC1 (0.45) | NOS3NOS1NOS2GRIN2DGRIN3B | |
| SCHEMBL4890075 | 0.87 | RAC1 (0.45) | NOS3NOS1NOS2GRIN2DGRIN3B | |
| SCHEMBL7261951 | 0.86 | KDM4E (0.53) | NOS3NOS1NOS2GRIN2DGRIN3B | |
| SCHEMBL6227985 | 0.86 | KDM4E (0.53) | NOS3NOS1NOS2GRIN2DGRIN3B | |
| SCHEMBL5354758 | 0.85 | GRIN2D (0.45) | NOS3NOS1NOS2GRIN2DGRIN3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011089000-A1 | PROCESS FOR THE PREPARATION OF ETHYLENE COPOLYMER COMPOSITIONS IN THE PRESENCE OF AN OLIGOMERIZATION CATALYST | BASELL POLYOLEFINE GMBH (DE) | 2011-07-28 | — | — | WO | disclosed |
| US-20080021180-A1 | CHROMIUM CATALYSTS ACTIVE IN OLEFIN POLYMERIZATION | REPSOL QUIMICA, S.A. | 2008-01-24 | — | — | US | disclosed |
| EP-1325924-B1 | Chromium catalysts active in olefin polymerisation | REPSOL QUIMICA SA (ES) | 2005-03-16 | — | — | EP | disclosed |
| US-20040087434-A1 | Chromium catalysts active in olefin polymerization | REPSOL QUIMICA, S.A. (ES) | 2004-05-06 | — | — | US | disclosed |
| EP-1325924-A1 | Chromium catalysts active in olefin polymerisation | REPSOL QUIMICA S.A. (ES) | 2003-07-09 | — | — | EP | disclosed |
| EP-1325925-A1 | Chromium catalysts active in olefin polymerization | REPSOL QUIMICA S.A. (ES) | 2003-07-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040087434-A1 | Chromium catalysts active in olefin polymerization | CBR1, SCO2, CBR3 | NOS3 1543/4885NOS1 1113/4885NOS2 1675/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.